(Image source from: Ndtv.com)

The government is preparing to launch a countrywide free vaccination program against Human Papillomavirus (HPV) for teenage girls to help prevent cervical cancer, according to sources from the Health Ministry. The initiative will provide free vaccinations at government health centers, focusing on girls who are 14 years old across the nation. The vaccination will be optional and given at no cost at specific government health facilities, which include Ayushman Arogya Mandirs, community and district hospitals, and government medical colleges. Health Ministry insiders have stated that all vaccination events will be overseen by qualified medical professionals, with procedures in place for monitoring and managing rare side effects after vaccination. With this program's launch, India will become one of over 160 countries that have added HPV vaccination to their national immunization plans. The vaccine supply for this nationwide effort has been obtained through a globally supported purchase system due to India’s collaboration with Gavi, the Vaccine Alliance, which guarantees that the vaccines are of high quality and adhere to regulatory and temperature control standards, as noted by sources.

This rollout is based on scientific assessments and suggestions from the National Technical Advisory Group on Immunisation (NTAGI). The HPV vaccination program in India will utilize the quadrivalent vaccine Gardasil, which protects against HPV types 16 and 18, associated with cervical cancer, as well as types 6 and 11. Cervical cancer ranks as the second most frequent cancer among women in India, with approximately 80,000 new cases and over 42,000 deaths reported each year, as per official statistics. According to Health Ministry sources, ongoing infection with high-risk HPV types, especially types 16 and 18, is responsible for more than 80 percent of cervical cancer cases in the nation. HPV vaccines are well-established in their global safety and effectiveness, with more than 500 million doses given around the world since 2006. Evidence reviewed by health authorities indicates that the vaccine is 93 to 100 percent effective in preventing cervical cancer from HPV types covered by the vaccine, sources have stated.
Vaccinating girls at the advised age, before they encounter the virus, helps lessen the long-term effects of cervical cancer and enhances preventive healthcare for women.

Human Papillomavirus consists of a range of common viruses, some of which can be spread through direct skin contact. Most HPV infections clear up on their own, but ongoing infection with certain high-risk strains, mainly HPV 16 and 18, can eventually result in cervical cancer. The vaccine provides the most preventive advantage when administered before exposure to the virus. Offering the vaccine to girls at the age of 14 ensures they are protected well before any potential infection occurs, contributing to lasting immunity and greatly lowering the future risk of cervical cancer. Studies from both global and Indian health authorities demonstrate strong and lasting protection when the vaccine is given during this age range.